Rocket Lab falls 64% since May in a space-stock rout and a Neutron delay
Why has Rocket Lab stock fallen so much?
Rocket Lab has lost about two-thirds of its value since its May 27 record close. Space stocks fell together: the slide began in late May and deepened when SpaceX listed in June, and peers such as AST SpaceMobile and Planet Labs fell even more. Along the way Rocket Lab sold about $3 billion of new stock, including $1.94 billion for its Iridium deal, and on Oct 14 it pushed the first launch of its bigger Neutron rocket into 2027.
- Move since May
- ▼ 64.2%
- Peak → now
- $150.23 → $53.82
- Value lost
- ~$55B
- Neutron first launch
- 2027 (no date yet)
- Backlog (Jun 30)
- $2.36B, +137% YoY
- New stock sold
- ~$3.0B since May 20
Prices: closing price, Oct 26, 2026 · Company data: 10-Q, Jun 30, 2026 · What these numbers mean
Closing prices (Yahoo Finance; Oct 26 close matches Nasdaq data) through Oct 26, 2026. Market value lost is our estimate: about 580–590 million shares × $150.23 at the peak (~$88B) vs about 628 million × $53.82 now (~$34B), counting the Series A preferred stock issued to CEO Peter Beck's trust in exchange for common shares (common shares alone: about 598 million, ~$32B). The share count rose about 7% after the peak because of stock sales.
Snapshot at the Oct 26, 2026 close
- Market value
- $32.2BIncluding the Series A preferred stock: $34.4B
- Enterprise value
- $29.9B
- Price/sales
- 41.9×
- EV/sales
- 38.9×
- P/E
- n/m
- Price/FCF
- n/m
- Revenue growth
- +53%
- FCF margin
- −48%
- Net cash
- $2.3B
Our calculation from the company's filings (latest: 10-Q for the quarter to Jun 30, 2026, filed Aug 10, 2026); not investment advice. Revenue, earnings and cash flow: 12 months to Jun 30, 2026. Price $53.82; 598.4 million shares (common shares on the cover page of the 10-Q filed Aug 10, 2026). n/m = not meaningful (e.g. negative earnings).
- : Record close
- : SpaceX starts trading; space stocks sold
- : $8B deal to buy Iridium announced
- : CEO's trust finishes $286M share sale
- : $1.94B stock sale for Iridium completed
- : Neutron debut pushed to 2027
Price data
| Date | Close |
|---|---|
| Mar 31, 2026 | $64.22 |
| Apr 30, 2026 | $82.51 |
| May 7, 2026 | $78.58 |
| May 15, 2026 | $124.77 |
| May 27, 2026 | $150.23 |
| Jun 5, 2026 | $110.08 |
| Jun 11, 2026 | $114.78 |
| Jun 12, 2026 | $102.39 |
| Jun 25, 2026 | $80.69 |
| Jun 30, 2026 | $101.65 |
| Jul 8, 2026 | $83.35 |
| Jul 16, 2026 | $67.35 |
| Jul 29, 2026 | $58.60 |
| Aug 7, 2026 | $82.83 |
| Aug 21, 2026 | $72.57 |
| Sep 2, 2026 | $63.10 |
| Sep 15, 2026 | $63.55 |
| Sep 25, 2026 | $73.95 |
| Oct 6, 2026 | $75.06 |
| Oct 13, 2026 | $64.22 |
| Oct 15, 2026 | $55.25 |
| Oct 20, 2026 | $50.90 |
| Oct 23, 2026 | $52.60 |
| Oct 26, 2026 | $53.82 |
Same period: S&P 500 (SPY) +2% · Space ETF (UFO) −39% · AST SpaceMobile −70% · Planet Labs −73%
Timeline
The stock peaked in late May, fell with other space stocks through the summer, and took a company-specific hit in October.
- May 7–27: After record first-quarter results, the stock nearly doubled in three weeks, to a record close of $150.23.
- May 20–Jun 30: Rocket Lab sold about $1.06 billion of new stock under a $3 billion program, at an average of about $136 a share (our math from SEC filings).
- Jun 12: SpaceX began trading, and Rocket Lab fell about 11% that day. It was already down about 24% from its record by Jun 11.
- Jun 29: Rocket Lab agreed to buy satellite operator Iridium for $27 in cash plus Rocket Lab shares per Iridium share, subject to an exchange-ratio collar, valuing Iridium at about $8 billion including debt.
- Jul 6–8: A family trust of CEO Peter Beck sold about $286 million of shares.
- Aug 13–Sep 15: Rocket Lab sold 29.3 million more shares for $1.94 billion to pay the cash part of the Iridium deal. Iridium’s stockholders approved the deal on Sep 24.
- Oct 14: After the close, Rocket Lab said Neutron’s first launch moves into 2027. The stock fell 6.6% the next day.
What’s driving it
Sector and market
Space stocks fell together, so much of the drop is not specific to Rocket Lab. Over the same period AST SpaceMobile fell 70%, Planet Labs 73% and Firefly 68%, while the S&P 500 rose about 2% (see the comparison above).
The slide began before SpaceX listed: Rocket Lab was already down about 24% from its record by Jun 11. On SpaceX’s first trading day, Reuters reported that investors might be selling smaller space stocks to make room for SpaceX; Talley Léger of The Wealth Consulting Group called it “capital recycling.” That is a possible explanation, not a measured flow of money.
Company-specific
Rocket Lab’s own developments during the decline were heavy stock sales, insider sales and another Neutron delay.
- The company sold about $3 billion of new stock. About $1.06 billion came in late May and June, near the top, and $1.94 billion from mid-August to mid-September for the Iridium deal. Iridium’s shareholders will also receive Rocket Lab stock at closing.
- Insiders sold heavily after the peak. Beck’s trust sold under a trading plan adopted on Mar 27, before the peak and the Iridium deal, per his Form 4 filings. Other executives and directors sold about $70 million from May 27 to Oct 1, about $15 million of it to cover taxes on vesting shares.
- Neutron slipped again. Neutron is Rocket Lab’s planned reusable medium-lift rocket, a big step up from its small Electron. The company found voids, small air pockets between carbon-fiber layers, in a first-stage propellant-tank dome. Beck said the voids “don’t necessarily mean that the dome would fail in flight,” but they cut the safety margin, so the part is being rebuilt (The Register). As late as Aug 10, the company said tank production was aligned with delivering Neutron to the launch pad in the fourth quarter.
The Neutron news hit Rocket Lab harder than its peers. From the Oct 14 close, just before the announcement, to Oct 26 the stock fell 9%, while the UFO space ETF rose 2%, AST SpaceMobile fell 6% and Planet Labs 3%.
The business itself kept growing. Rocket Lab reported second-quarter revenue of $234 million, up 62% from a year earlier, and a record $2.36 billion backlog, up 137%. It still loses money: $94 million in the first half of 2026.
Where it could go from here
These are other people’s views, not ours.
What analysts and the market think
Analysts remain mostly positive, though several cut their targets after the delay. Of 22 analysts tracked by Yahoo Finance, 18 rate the stock buy or strong buy and 4 hold, with no sells. Their average 12-month price target is about $102, nearly double the latest price, in a range of $64 to $150. On Oct 15, KeyBanc kept its Overweight rating but cut its target to $100 from $135, citing one fewer revenue-generating launch in 2027 and lower valuations across fast-growing space stocks (Investing.com). Cantor Fitzgerald kept Overweight and a $122 target.
Goldman Sachs is the notable skeptic. On Oct 15 it kept a Neutral (hold) rating and cut its target to $67 from $75, expecting the delay to add expenses and cash burn over the next few quarters (TipRanks). Analysts’ average 2027 loss forecast has also widened over the past 90 days, to about 9 cents a share from about 3 cents (Yahoo Finance). About 44 million shares, roughly 7% of all shares, were sold short at the end of September (Yahoo Finance).
Is the valuation reasonable?
Against its own peak the stock is far cheaper; against peers it still sits near the top. At the May peak, Rocket Lab’s market value was about 146 times its 2025 sales of about $600 million; it is now about 54 times on common shares, or about 56 times including the Series A preferred (our math). Measured by enterprise value to this year’s expected sales, it trades at about 31 times: below SpaceX, but well above Planet Labs, Firefly and Iridium.
Has the long-term story changed?
The plan is the same; the timing and the share count changed. Rocket Lab says Neutron is late, not cancelled, and that the dome problem is fixed (The Register). Iridium would add a steady, profitable business: $872 million of 2025 revenue and $495 million of operational EBITDA (OEBITDA), an adjusted earnings measure that excludes interest, taxes, depreciation, amortization, share-based pay and some other items, per Rocket Lab’s deal release.
| Company | EV/sales 2026e | EV/sales 2027e | Since May 27 |
|---|---|---|---|
| Rocket Lab RKLB | ~31× | ~22× | −64% |
| SpaceX SPCX1 | ~40× | ~11× | −9% |
| AST SpaceMobile ASTS | ~79× | ~22× | −70% |
| Planet Labs PL2 | ~10× | ~8× | −73% |
| Firefly Aerospace FLY | ~6× | ~4× | −68% |
| Iridium IRDM (Being bought by Rocket Lab) | ~7× | ~7× | −13% |
- Listed Jun 12; change is from its first-day close. Over half of its Q3 revenue came from its AI unit (Q3 8-K), so it is an imperfect comparison.
- Fiscal years end in January (2026e = year to Jan 2027).
The 3–5 year view for long-term investors
Again, these are other people’s forecasts, not ours.
- Analysts expect revenue of about $960 million in 2026 (+59%) and $1.33 billion in 2027 (+38%), per Yahoo Finance consensus.
- Iridium’s management forecast, published in the merger proxy, has Iridium’s revenue growing slowly, to about $1.0 billion in 2030, with about $600 million of adjusted OEBITDA. Rocket Lab says the deal will be “significantly accretive” to its cash flow and profitability and that it will support the development and deployment of Iridium’s next-generation constellation.
- Neutron is the swing factor. CFO Adam Spice has said positive cash flow is “very much a function of the timing of the first successful test launch of Neutron,” coming 18 to 24 months after that (24/7 Wall St). Citizens said the delay’s biggest impact is on how quickly Rocket Lab can earn money from Neutron launches in 2027 and 2028 (Yahoo Finance).
- The risks analysts cite include slower Neutron revenue (Citizens), higher costs and cash burn (Goldman Sachs) and lower valuations across fast-growing space stocks (KeyBanc).
What would change the story
The next milestones are the third-quarter results on Nov 9, completion of Neutron’s tank tests and a new launch date, and progress toward closing the Iridium deal.
Our read
Rocket Lab’s shares fell from a record that valued the company at about 146 times last year’s sales, and they fell alongside other space stocks. Its own setbacks were heavy stock issuance and another Neutron delay, while revenue and backlog kept growing. The next tests are the Nov 9 results and Neutron’s tank tests in early 2027.
What to watch next
- Nov 9 (confirmed)
- Third-quarter results after the close. Guidance was $250–265 million in revenue; watch Neutron costs and cash burn.
- Q1 2027
- Neutron's rebuilt first stage should finish pressure and cryogenic testing. Rocket Lab says it will set a launch date only after that.
- Mid-2027 (expected)
- The Iridium deal is expected to close, pending regulatory approvals. Iridium's stockholders approved it on Sep 24.
Quick questions
Is Rocket Lab's fall mostly about SpaceX?
Space stocks fell together: AST SpaceMobile, Planet Labs and Firefly fell 68–73% over the same period, more than Rocket Lab. Reuters reported that investors might be selling smaller space stocks to make room for SpaceX when it listed, but there is no measure of how much of the fall that explains. Rocket Lab's own extra drop came after the Oct 14 Neutron delay.
Did Rocket Lab's CEO sell shares?
A family trust of CEO Peter Beck sold about $286 million of stock on Jul 6–8, under a pre-arranged trading plan adopted on Mar 27, per SEC filings. Other insiders sold about $70 million from May 27 to Oct 1, about $15 million of it to cover taxes on vesting shares.
Is Rocket Lab profitable?
No. It lost $94 million in the first half of 2026 on revenue of $434 million. CFO Adam Spice has said positive cash flow would come 18–24 months after Neutron's first successful test launch (24/7 Wall St).
Is the Iridium deal done?
Not yet. It is fully funded, Iridium's stockholders approved it on Sep 24, and it is expected to close in mid-2027 pending regulatory approvals.
Updates
- : Corrected the valuation snapshot: market value now uses common shares outstanding (598.4 million on the 10-Q cover page, Aug 5, 2026), our standard basis, instead of 639.1 million shares including the Series A preferred stock; market value $32.2B (was $34.4B), with enterprise value and multiples recalculated. Prices and dates unchanged.
About Rocket Lab: Website (external site)Investor relations (external site)SEC filings (external site)Wikipedia (external site)
+ 12 more
Accessed Oct 26, 2026: Rocket Lab: Q2 2026 results (SEC 8-K) · Iridium: stockholder vote results (SEC 8-K), Sep 24 · Iridium: merger proxy with management forecast (SEC DEFM14A), Aug 26 · Rocket Lab: agreement to acquire Iridium (SEC 8-K) · Rocket Lab: stock-sale program and amount sold to date (SEC 424B5), Aug 13 · SEC: Form 4 filings, Peter Beck (Equatorial Trust), Jul 2026 · Reuters via Investing.com: space stocks slump on SpaceX debut, Jun 12 · Investing.com: KeyBanc cuts target, Oct 15 · TipRanks: Goldman Sachs cuts target to $67, Oct 15 · 24/7 Wall St: Neutron delay, CFO on cash flow, Oct 15 · Yahoo Finance: Citizens cuts target, Oct 16 · Yahoo Finance: prices, consensus and valuation
Quoting this? You may quote short excerpts under our reuse policy. Please credit WhyMyStockMoved.com and link to this page.